Monthly Archives : May 2016

Valeant’s former CEO may remain as consultant through 2017

NEW YORK (Reuters) - Michael Pearson, the former chief executive officer of Valeant Pharmaceuticals International , has signed a consulting agreement with the drugmaker that will run through 2017 and pay him hundreds of thousands of dollars, according to the separation agreement filed with regulators.     
Continue Reading

Wall St. opens higher on strong spending data

(Reuters) - U.S. stocks opened slightly higher on Tuesday after strong consumer spending data gave the latest sign of an improvement in economic growth and supported the Federal Reserve's stance to increase interest rates in the coming months.     
Continue Reading